Honorary Senior Clinical Lecturer (University of Dundee), Associate Medical Director for Access & Assurance (NHS Tayside), Consultant Cellular Pathologist (NHS Tayside), CMO’s Specialty Adviser for Cellular Pathology (CMO Office – Scotland)
+44 (0)1382 632920
Lee Jordan studied Medicine at the University of Edinburgh between 1991 and 1997. He also received a Medical Research Council Scholarship to study for an intercalated degree and graduated with a first class honours in Genetics (B.Sc.(Hons)) in 1996. Completion of his primary medical degree (M.B.,Ch.B.) followed in 1997.
Following clinical posts in Edinburgh and Dundee, Dr Jordan embarked upon his cellular pathology training in Edinburgh and became a Clinical Lecturer at Edinburgh University. Following achievement of the M.R.C.Path by examination, he spent a sabbatical at the University of Chicago (2003), completing training in 2004.
Dr Jordan was then appointed as a Consultant Cellular Pathologist with a specialist interest in Breast Pathology by NHS Tayside in 2004. He was also appointed as an Honorary Senior Clinical Teacher at that time and was promoted to an Honorary Senior Clinical Lecturer in 2011.
During his substantive career, Dr Jordan has been the Clinical Lead for NHS Tayside Pathology (2007-2013), the Clinical Lead for the Scottish (Cellular) Pathology Network (2013-2016), interim Clinical Director for Specialist Services (2018) and is the current Associate Medical Director for the Access & Assurance Clinical Care Division of NHS Tayside. He is also the current Speciality Adviser to the Scottish Chief Medical Officer for Cellular Pathology (2013 to date).
His research interests pertain to the pathological aspects of breast cancer and he conducts collaborative translational research alongside clinical trials activity and correlative studies with other imaging modalities including radiological imaging and computational imaging.
WORK FOR LOCAL BODIES
Associate Medical Director for Access & Assurance – 2018 to date.
‘Discovery Champion’ – 2016 to date.
Interim Clinical Director for Specialist Services – 2018.
Chair of the pilot Primary & Secondary Care Interface Group (PSCIG) – 2017.
Clinical Lead for Cellular Pathology (Histopathology & Cytopathology) – 2007-2013.
Invited Member of the Scottish (Cellular) Pathology Network (SPAN) – 2007-2013.
Invited Member of the Cancer Overview Group – 2007-2013.
Consultant Appraiser – 2007-2010.
Lead Consultant for Histopathology – 2005-2007.
University of Dundee
Invited Member of the Tayside Tissue Bank (now Tayside Biorepository) Access Committee – 2007-2018.
Invited Member of the Tayside Tissue Bank (now Tayside Biorepository) Management Committee – 2010-2016.
Invited member of the Cancer Informatics DECIPHER and Demonstrator project – 2011-2013.
Member of the National Breast Cancer Campaign Tissue Bank Operations Group – 2009-2011.
University of Edinburgh
Membership of the University of Edinburgh Senatus Academicus – 2003-2004.
Trainee representative to the local South East Scotland Histopathology and Laboratory Medicine Training committees – 2001-2003.
WORK FOR NATIONAL BODIES
Scottish Government Healthcare and Social Care Directorate
Scottish Chief Medical Officer’s (CMO) Specialty Adviser for Cellular Pathology 2013 to date.
Invited Member of the Scottish Medical and Scientific Advisory Committee (SMASAC) – 2013-2016.
NHS Scotland National Specialist Services – National Services Division
Lead Clinician for the Scottish (Cellular) Pathology Network (SPAN) – 2013-2016.
Invited Member of the Molecular Pathology Consortium Steering Group – 2013-2016.
Invited Member of the Diagnostics Steering Group – 2013-2016.
Invited Member of the Molecular Pathology Evaluation Panel – 2012-2013.
Invited member of the Scotland & Northern Ireland EQA Scheme Management Committee – 2006-2008.
Breast Cancer Now Tissue Bank
Grant holder and co-creator – 2009-2015.
Member of the Tissue Bank Operations Group – 2009-2011.
Member of the Access Committee – 2011-2015.
Royal College of Pathologists
Elected Member of the Scottish Regional Council – 2005-2008.
Scottish trainee representative to the Trainee Advisory Committee (TAC) – 2001-2003.
TAC Representative to the Specialty Advisory Committee on Histopathology – 2001-2003.
TAC Representative to the Scottish Regional Council – 2001-2003.
WORK FOR INTERNATIONAL BODIES
University of Chicago & The American Association of Pathologists’ Assistants
Invited Lecture and Workshop – 2004.
Peer review for scientific journals; local/national/international clinical trials work.
Lee Jordan is a full-time consultant and all research is carried out in addition to his clinical, administrative and leadership activities.
He has published scientific works that have been cited more than 3,500 times, 2,600 of these citations were in the past five years.
He has been awarded grants totalling more than £9 million.
His research has been presented nationally and internationally at numerous scientific meetings including:
- The San Antonio Breast Cancer Symposium (SABCS)
- American Society of Clinical Oncology (ASCO)
- American Association for Cancer Research (AACR)
- Radiological Society of North America (RSNA)
- American Society of Human Genetics (ASHG)
- Institute of Electrical and Electronics Engineers (IEEE)
- Medical Image Computing and Computer Assisted Intervention (MICCAI)
- National Cancer Research Institute (NCRI)
- European Breast Cancer Conference (EBCC)
- IMPAKT Breast Cancer Conference
- European Organisation for Research and Treatment of Cancer (EORTC)
- International Society for Biological and Environmental Repositories (ISBER)
- Pathological Society of Great Britain & Ireland
- British Society of Breast Radiology
- European Congress of Radiology
- Society for Mathematical Biology
- British Breast Group
He was invited to lecture to the American Association of Pathologists’ Assistants in Chicago in 2004 regarding the UK experience of autopsy pathology in light of the then recent organ retention scandal.
He has been invited to lecture both medical and non-medical staff across Scotland in relation to his national roles and also for post-graduate training. He has also contributed to the examination work of the R.C.Path.
He has contributed to local undergraduate medical education in relation to general pathology, cardiovascular pathology, breast pathology and human genetics. He has also provided post-graduate teaching and mentoring for non-medical staff undergoing medical role extension training and has provided secondary level supervision for M.D. and Ph.D. students.